The spikes in my eyes
Release time:
2020-08-14
The peak
■ Jiang Xiaomeng
in my eyes will be the 11th anniversary of the peak start-up 60# and the 38 year of my work in the peak. From a young and ignorant teenager to now, my temples have begun to turn white. I have witnessed the nearly 2/3 course of the peak, including glory and depression, but more hope and longing.
Fortune magazine has reported that the average life expectancy of small and medium-sized enterprises in the United States is less than 7 years, while that of large enterprises is less than 40 years. The average life span of China's small and medium-sized enterprises is 2.5 years, and the average life span of group enterprises is 7 to 8 years. Among the many enterprises in our country, very few have the same peak life as us.
The peak with history
The development of the peak has experienced many great turning points worthy of memory and commemoration, such as setting up cement factory, cross-industry acquisition, merger, diversified operation, integration of pharmaceutical industry... Fortunately, I am a witness to these great events, even a witness.
When I entered the factory, in 1980 , Jinhua Cement Factory was still in the stage of coexistence of ordinary vertical kilns and mechanical vertical kilns. At that time, in the firing workshop, most of the feeding and unloading in the production process depended on manual work. When commuting in winter, you can often see the "brilliant" image of workers wearing hoods, working cotton-padded jackets, and rice basins under their armpits. Because the buttons of the cotton-padded jacket are easy to fall off, some employees still root straw ropes in their waists. The working conditions at that time could not be compared with those now. The dust was flying when adding and unloading materials. At the end of the day, everyone became the same appearance-because they were wearing masks, there were two black shadows on the bridge of the nose, and their bodies were covered in gray. Some people had too much dust on their faces and their eyebrows looked white.
Due to the lack of economy at that time, cement was regarded as a "tight commodity". The roads outside the factory area were full of cars buying cement, large trucks and small tractors, with long lines and even overnight queues. Sometimes it took two or three days for their turn. One winter when it snowed heavily and blocked the road, vehicles transporting limestone could not get in, and production was about to stop. At that time, I was still working in the raw material workshop. The factory organized employees to sweep snow and sweep all the way to the Kowloon mine along the Shuanglong Highway.
Although the working environment is so difficult, we have a sense of superiority regardless of cadres or employees, because we are workers!
With the progress of science and technology and the development of enterprises, 20th century 80# In the mid-1950s, Jianfeng established two branch factories and three branch factories successively through cooperation with township enterprises. Later, he established a building materials group and built the first batch of rotary kiln production lines in Zhejiang Province, which was later Jinma Factory. After entering 21nd century, we went out of the basin and built factories in Fuyang across regions. Until now, Jianfeng Cement has taken root in many provinces and cities across the country.
90 s of the last century, was the first step in the development of Jianfeng across industries. As the first general manager of a cable company, I started from scratch to supplement basic cable courses, engaged in construction, production, and market with my colleagues, and sold peak cables to most provinces and cities across the country. In 1996 , Jianfeng cross-regional merger of Linhai Pharmaceutical Factory, reorganization of the establishment of Zhejiang Jianfeng Haizhou Pharmaceutical Co., Ltd., to build a raw material drug production base. This requires considerable boldness when talents, technology and other factors were not available at that time. Although this first step was not satisfactory and later withdrew, this merger accumulated experience and trained a team for the development of Jianfeng in the pharmaceutical field. Only then did it acquire Jinhua Biochemical Pharmaceutical Factory, set up Jianfeng Pharmaceutical Company, and took a stake in Tianshili Group, finally forming a development pattern of cement and pharmaceutical dual main businesses.
tons to a cross-industry and cross-regional comprehensive enterprise group, and finally form a development strategy of "cooperative innovation to strengthen the main business; standardize science and seek development". It has created the current achievements of the peak.
3800 kilometers; "Jianfeng" brand cement is a famous brand product in Zhejiang, Hubei, Yunnan and other provinces and cities; all environmental protection indicators have reached or led the international and domestic standards, and the production process and technical indicators are among the best in the country. It is in cost control, quality control, The profit indicators of tons of cement are all ahead of the same industry, and this year has achieved the best results in history. The
76 document numbers, exceeding the sales of 10 .1 billion yuan. It has recruited talents from all walks of life in the country and trained a large number of teams who are loyal to the peak, love their posts and work hard, bear hardships and stand hard work, have combat effectiveness and professional qualities. In Tianjin, we have Tianjin Jianfeng Natural Products Company, a leading enterprise of plant extracts in China; in Jinhua, we have recently built a large-scale Jinxi pharmaceutical base and set up a Sino-German joint venture Jinder Baby Drug Company; this year, we have also participated in Beijing Huibaoyuan Biotechnology Company ...... While the pharmaceutical territory continues to expand, the health industry sector centered on Jianfeng Health Technology Company is also showing its embryonic form.
DPT under development is also the first major national innovation project in Jinhua's history. Many products have also been listed as the national high-tech industrialization demonstration project, the national key new product plan project and the national torch plan project. Cefmenoxime hydrochloride for injection has also created a history of over 100 million yuan in sales of single products; peak Pharmaceutical has also been rated as a national high-tech enterprise for more than 10 years.
Now, the peak is about to enter the 107 60
Finally, I would also like to thank the old peak people of all ages for their efforts in the cause of peak. We will not forget those old leaders, old employees, and old colleagues who have worked hard for the peak cause. Their conscientious and selfless dedication is the source and driving force of the development of the enterprise, and it also inspires generations of peak people to move forward courageously on the road of a century-old peak.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31